Hubungan derajat albuminuria dengan beratnya lesi arteri koroner pada pasein penyakit jantung koroner
DAFTAR RUJUKAN
1. World Health Organization Deaths from Coronary Heart Disease. 2014.
Available
from:http://www.who.int/mediacentre/factsheets/fs310/en/index2.html.
2. Departemen Kesehatan RI. Riset Kesehatan Dasar 2013.2014. Available
from:http://depkes.go.id/downloads/riskesdas2013/Hasil%20Riskesdas%2020
13.pdf.
3. Montalescot G, Sechtem u, Achenbaach S, Andreotti F, Arden C, Budaj A, et
al.2014 ESCguielines on the managementof stable coronary disease.
European Heart Journal 2013;34:2949-3003
4. Valentin F, Wayne A, obert A, ’ ourke. Cardiac Catheterization, Cardiac
Angiography and Coronary Blood Flow and pressure Measurements. In Hurts
The Heart. 17 thed.20144;17:483-537
5. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey
:2001 emergency department summary. Adv Data 2004;320:1-34.
6. Hansson GK. Inflammation, Atheroslerosis, and Coronary Artery Disease. N
Engl J Med 2007;352 (16): 168-95
7. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H,
et al. Estimation of contribution of changes in classic risk factors to trends in
coronary-event rates across the WHO MONICA Project populations. Lancet
2000; 355(9205): 675-87.
8. Rahman AM. Angina Pektoris Stabil. Dalam: Sudoyo AW, Setiyohadi B,
Alwi I, Simadibrata M, Seriati S (eds). Buku Ajar Penyakit Dalam. Ed 4.
Jakarta. Pusat Penerbitan Departemen Ilmu Penyakit Dalam FK-UI.
2014:1626-8.
9. Ritz E. Albuminuria and vascular damage – The vicious twins. N Engl J Med.
2003; 348(23):2349-52.
10. Yudkin JS. Microalbuminuria in vascular disease. In: Mogensen CE (ed).
Microalbuminuria a marker for organ damage. Science Press London
1996:76-86.
Universitas Sumatera Utara
11. Albuminuria and risk of cardiovascular event, death and heart failure in
diabetic and nondiabetic individuals. JAMA 2001;286:421-26.
12. Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic
significance of microalbuminuria in insulin-dependent diabetes mellitus: a
twenty-three year follow-up study. Kidney Int 1992; 41(4): 836-9.
13. Park HY, Schumock GT, Pickard AS, Akhras K. A structured review of the
relationship between microalbuminuria and cardiovascular events in patients
with diabetes mellitus and hypertension. Pharmacotherapy 2003; 23(12):
1611-6.
14. Majid A. Penyakit Jantung Koroner: Patofisiologi, Pencegahan dan
Pengobatan Terkini. Pidato Pengukuhan Jabatan Guru Besar Bidang Ilmu
Fisiologi Fakultas Kedokteran Universitas Sumatera Utara, Medan, 4 Agustus
2007.
15. Braunwald E, Antmann
EM, et al. ACC/AHA Guidelines for the
Management of Patients With Unstable Angina and Non-ST Segment
Elevation
Myocardial
Infarction:
Executive
Summary
and
Recommendations.ACC/AHA Practice Guidelines. Cicrculation. 2002;102:
1193-1209.
16. Libby Peter, Theroux Pierre. Pathophysiology of Coronary Artery Disease.
Circulation. 2005; 111: 3481-3488.
17. Anwar TB. Dislipidemi sebagai Faktor Resiko Penyakit Jantung Koroner. EUSU Repository Fakultas Kedokteran Universitas Sumatera Utara. 2004
18. Califf R. M, Antman EM, Grines CL, Kereiakes D, Bernink PJ, Fox KAA.
Acute Coronary Syndromes: A Transtition in Treatment Standards. Journal of
the European Society of Cardiology. 2000;2 (Suplement F): F2-24.
19. Lauer Michael. Primary Prevention of Atherosclerotic Cardiovascular
Disease. JAM. 2007; 297: 1376-1378
20. Stone NJ, Robinson J, Lichtenstein AL, Bairey Merz CN, Blum CB, Eckel
EH. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to
Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the
Universitas Sumatera Utara
American College of Cardiology/American Heart Association Task Force on
Practice Guidelines. Circulation. 2013:12:1-85
21. Viberti GC, Jarrett RJ, Keen H. Microalbuminuria as prediction of
nephropathy in diabetics. Lancet. 1982;2:611.
22. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early
mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356–360.
23. Stehouwer CDA, Nauta JJ, Zeldenrust GC, et al. Urinary albumin excretion,
cardiovascular disease, and endothelial dysfunction in non-insulin-dependent
diabetes mellitus. Lancet. 1992;340:319–323.
24. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality
in non-insulin-dependent diabetes mellitus. A systematic overview of the
literature. Arch Intern Med. 1997;157:1413–1418.
25. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular
events, death, and heart failure in diabetic and nondiabetic individuals.
JAMA. 2001;286:421–426.
26. Jones CA, Francis ME, , et al. Micro-albuminuria in the US population: third
national health and nutrition examination survey. Am J Kidney Dis.
2002;39:445–459.
27. Gall MA, Borch-Johnsen K, et al. Albuminuria and poor glycemic control
predict mortality in NIDDM. Diabetes. 1995;44:1303–1309.
28. Borch-Johnsen K. Incidence of nephropathy in IDDM as related to mortality.
Costs and benefits of early intervention. In: Mogensen CE, ed. The Kidney
and
Hypertension
in
Diabetes
Mellitus.
Boston,
MA:
Kluwer
AcademicPublishers; 2001:169–178.
29. Allen KV, Walker JD. Microalbuminuria and mortality in longdurationtype 1
diabetes. Diabetes Care. 2003;26:2389–2391.
30. Tuttle KR, Puhlman ME, Cooney SK, et al. Urinary albumin and insulin as
predictors of coronary artery disease: an angiographic study. Am J Kidney
Dis. 1999;34:918–925.
31. Jarrett RJ, Viberti GC, Argyropoulos A, et al. Microalbuminuria predicts
mortality in non-insulin-dependent diabetics. Diabet Med. 1984;1:17–19.
Universitas Sumatera Utara
32. Morgensen CE, Damsgaard EM, Froland A, et al. Microalbuminuria in noninsulin-dependent diabetes. Clin Nephrol. 1992;38:528–538.
33. Mattock MB, Barnes DJ, Viberti G, et al. Microalbuminuria and coronary
heart disease in NIDDM: an incidence study. Diabetes. 1998;47:1786–1792.
34. Damsgaard EM, Froland S, Jorgensen OD, et al. Microalbuminuria as
predictor of increased mortality in elderly people. BMJ. 1990;300:297–300.
35. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure
with macrovascular and microvascular complications of type 2 diabetes
(UKPDS 36): prospective observational study. BMJ. 2000;321:412–419.
36. Rossing P, Hougaard P, Borch-Johnsen K, et al. Predictors of mortality in
insulin dependent diabetes: 10 year observational follow up study. BMJ.
1996;313:779–784.
37. Agewall S, Wikstrand J, Ljungman S, et al. Does microalbuminuria predict
cardiovascular events in nondiabetic men with treated hypertension? Am J
Hypertens. 1995;8:337–342.
38. Agewall S, Wikstrand J, Ljungman S, et al. Urinary albumin excretion is
associated with the intima-media thickness of the carotid artery in
hypertensive males with non-insulin-dependent diabetes mellitus. J
Hypertens. 1995;13:463–469.
Universitas Sumatera Utara
1. World Health Organization Deaths from Coronary Heart Disease. 2014.
Available
from:http://www.who.int/mediacentre/factsheets/fs310/en/index2.html.
2. Departemen Kesehatan RI. Riset Kesehatan Dasar 2013.2014. Available
from:http://depkes.go.id/downloads/riskesdas2013/Hasil%20Riskesdas%2020
13.pdf.
3. Montalescot G, Sechtem u, Achenbaach S, Andreotti F, Arden C, Budaj A, et
al.2014 ESCguielines on the managementof stable coronary disease.
European Heart Journal 2013;34:2949-3003
4. Valentin F, Wayne A, obert A, ’ ourke. Cardiac Catheterization, Cardiac
Angiography and Coronary Blood Flow and pressure Measurements. In Hurts
The Heart. 17 thed.20144;17:483-537
5. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey
:2001 emergency department summary. Adv Data 2004;320:1-34.
6. Hansson GK. Inflammation, Atheroslerosis, and Coronary Artery Disease. N
Engl J Med 2007;352 (16): 168-95
7. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H,
et al. Estimation of contribution of changes in classic risk factors to trends in
coronary-event rates across the WHO MONICA Project populations. Lancet
2000; 355(9205): 675-87.
8. Rahman AM. Angina Pektoris Stabil. Dalam: Sudoyo AW, Setiyohadi B,
Alwi I, Simadibrata M, Seriati S (eds). Buku Ajar Penyakit Dalam. Ed 4.
Jakarta. Pusat Penerbitan Departemen Ilmu Penyakit Dalam FK-UI.
2014:1626-8.
9. Ritz E. Albuminuria and vascular damage – The vicious twins. N Engl J Med.
2003; 348(23):2349-52.
10. Yudkin JS. Microalbuminuria in vascular disease. In: Mogensen CE (ed).
Microalbuminuria a marker for organ damage. Science Press London
1996:76-86.
Universitas Sumatera Utara
11. Albuminuria and risk of cardiovascular event, death and heart failure in
diabetic and nondiabetic individuals. JAMA 2001;286:421-26.
12. Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic
significance of microalbuminuria in insulin-dependent diabetes mellitus: a
twenty-three year follow-up study. Kidney Int 1992; 41(4): 836-9.
13. Park HY, Schumock GT, Pickard AS, Akhras K. A structured review of the
relationship between microalbuminuria and cardiovascular events in patients
with diabetes mellitus and hypertension. Pharmacotherapy 2003; 23(12):
1611-6.
14. Majid A. Penyakit Jantung Koroner: Patofisiologi, Pencegahan dan
Pengobatan Terkini. Pidato Pengukuhan Jabatan Guru Besar Bidang Ilmu
Fisiologi Fakultas Kedokteran Universitas Sumatera Utara, Medan, 4 Agustus
2007.
15. Braunwald E, Antmann
EM, et al. ACC/AHA Guidelines for the
Management of Patients With Unstable Angina and Non-ST Segment
Elevation
Myocardial
Infarction:
Executive
Summary
and
Recommendations.ACC/AHA Practice Guidelines. Cicrculation. 2002;102:
1193-1209.
16. Libby Peter, Theroux Pierre. Pathophysiology of Coronary Artery Disease.
Circulation. 2005; 111: 3481-3488.
17. Anwar TB. Dislipidemi sebagai Faktor Resiko Penyakit Jantung Koroner. EUSU Repository Fakultas Kedokteran Universitas Sumatera Utara. 2004
18. Califf R. M, Antman EM, Grines CL, Kereiakes D, Bernink PJ, Fox KAA.
Acute Coronary Syndromes: A Transtition in Treatment Standards. Journal of
the European Society of Cardiology. 2000;2 (Suplement F): F2-24.
19. Lauer Michael. Primary Prevention of Atherosclerotic Cardiovascular
Disease. JAM. 2007; 297: 1376-1378
20. Stone NJ, Robinson J, Lichtenstein AL, Bairey Merz CN, Blum CB, Eckel
EH. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to
Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the
Universitas Sumatera Utara
American College of Cardiology/American Heart Association Task Force on
Practice Guidelines. Circulation. 2013:12:1-85
21. Viberti GC, Jarrett RJ, Keen H. Microalbuminuria as prediction of
nephropathy in diabetics. Lancet. 1982;2:611.
22. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early
mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356–360.
23. Stehouwer CDA, Nauta JJ, Zeldenrust GC, et al. Urinary albumin excretion,
cardiovascular disease, and endothelial dysfunction in non-insulin-dependent
diabetes mellitus. Lancet. 1992;340:319–323.
24. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality
in non-insulin-dependent diabetes mellitus. A systematic overview of the
literature. Arch Intern Med. 1997;157:1413–1418.
25. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular
events, death, and heart failure in diabetic and nondiabetic individuals.
JAMA. 2001;286:421–426.
26. Jones CA, Francis ME, , et al. Micro-albuminuria in the US population: third
national health and nutrition examination survey. Am J Kidney Dis.
2002;39:445–459.
27. Gall MA, Borch-Johnsen K, et al. Albuminuria and poor glycemic control
predict mortality in NIDDM. Diabetes. 1995;44:1303–1309.
28. Borch-Johnsen K. Incidence of nephropathy in IDDM as related to mortality.
Costs and benefits of early intervention. In: Mogensen CE, ed. The Kidney
and
Hypertension
in
Diabetes
Mellitus.
Boston,
MA:
Kluwer
AcademicPublishers; 2001:169–178.
29. Allen KV, Walker JD. Microalbuminuria and mortality in longdurationtype 1
diabetes. Diabetes Care. 2003;26:2389–2391.
30. Tuttle KR, Puhlman ME, Cooney SK, et al. Urinary albumin and insulin as
predictors of coronary artery disease: an angiographic study. Am J Kidney
Dis. 1999;34:918–925.
31. Jarrett RJ, Viberti GC, Argyropoulos A, et al. Microalbuminuria predicts
mortality in non-insulin-dependent diabetics. Diabet Med. 1984;1:17–19.
Universitas Sumatera Utara
32. Morgensen CE, Damsgaard EM, Froland A, et al. Microalbuminuria in noninsulin-dependent diabetes. Clin Nephrol. 1992;38:528–538.
33. Mattock MB, Barnes DJ, Viberti G, et al. Microalbuminuria and coronary
heart disease in NIDDM: an incidence study. Diabetes. 1998;47:1786–1792.
34. Damsgaard EM, Froland S, Jorgensen OD, et al. Microalbuminuria as
predictor of increased mortality in elderly people. BMJ. 1990;300:297–300.
35. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure
with macrovascular and microvascular complications of type 2 diabetes
(UKPDS 36): prospective observational study. BMJ. 2000;321:412–419.
36. Rossing P, Hougaard P, Borch-Johnsen K, et al. Predictors of mortality in
insulin dependent diabetes: 10 year observational follow up study. BMJ.
1996;313:779–784.
37. Agewall S, Wikstrand J, Ljungman S, et al. Does microalbuminuria predict
cardiovascular events in nondiabetic men with treated hypertension? Am J
Hypertens. 1995;8:337–342.
38. Agewall S, Wikstrand J, Ljungman S, et al. Urinary albumin excretion is
associated with the intima-media thickness of the carotid artery in
hypertensive males with non-insulin-dependent diabetes mellitus. J
Hypertens. 1995;13:463–469.
Universitas Sumatera Utara